Dr. Mohandas Narla, D.Sc. is Vice President for Research of New York Blood Center. He received his doctoral degree from Washington University in St. Louis in Chemical Engineering in 1971. After completing post-doctoral training in hematology research with Dr. Marcel Bessis at Institute of Cellular Pathology in Paris, he joined the faculty of the Department of Laboratory Medicine at University of California in 1976 where he spent 13 years. In 1989, he moved to Lawrence Berkeley National Laboratory, University of California to head the Hematopoiesis group. During his 12 year tenure at the Berkeley Laboratory he also served as Interim Director of the Human Genome Project for three years. In 2001, he moved to the New York Blood Center.
His scientific interests have long focused on red cell physiology and pathology. In particular, his efforts have contributed to improved understanding of the molecular and structural basis for red cell membrane disorders, developing detailed mechanistic insights into pathophysiology of thalassemia’s and sickle cell anemia, characterizing structural and functional changes induced in red cells by the malarial parasite, plasmodium falciparum and more recently molecular understanding of erythropoiesis with particular emphasis on disordered erythropoiesis in Diamond-Blackfan Anemia and Myelodysplasia. He has authored 340 peer-reviewed publications and 100 review articles and book chapters.
Dr. Narla has and continues to serve as a member of numerous NIH review and advisory panels for the last 30 years. He has been a member of numerous committees of the American Society of Hematology including the Executive Committee and is currently Chairperson of the Awards Committee. He is served as Associate Editor of Blood from 2003-2012 and is currently an Editorial Board of numerous journals including Journal of Biological Chemistry, Biochemistry and Current Opinion in Hematology.